Whole Body Cryotherapy and Hyperbaric Oxygen Treatment: New Biological Treatment of Depression? A Systematic Review
Krzystanek M, Romańczyk M, Surma S, Koźmin-Burzyńska A
Pharmaceuticals (Basel, Switzerland) · 1 citation
How it was studied
- Design
- Systematic review (classified by our AI screen)
- Studied in
- People
- Main outcome
- Health markers and function
Who paid for it
- Funding
- Independent funding
Based on full-text disclosure statement.
Publication
- Published
- 2021-06-21 · Pharmaceuticals (Basel) · vol. 14 · issue 6 · p. 595
- Publisher
- Multidisciplinary Digital Publishing Institute
- Cited
- 11 citations · more than 26% of similar papers · 0.1× the field average
- References
- 29 works
- Access
- Open access (journal) · CC-BY
- Research areas
- Tryptophan and brain disorders · Fibromyalgia and Chronic Fatigue Syndrome Research · Genetic Neurodegenerative Diseases
- Keywords
- Depression (economics), Medicine, Antidepressant, Intensive care medicine, Cryotherapy, Pharmacotherapy, Clinical trial, Psychiatry, Internal medicine, Surgery, Anxiety
4 authors
From PL
- Marek Krzystanek · correspondingMedical University of Silesia; University of Silesia in Katowice
- Monika RomańczykMedical University of Silesia; University of Silesia in Katowice
- Stanisław SurmaMedical University of Silesia; University of Silesia in Katowice
- Agnieszka Koźmin-BurzyńskaMedical University of Silesia
Abstract
Treatment with antidepressants is often insufficiently effective, especially in treatment-resistant depression. In such a situation, it is possible to change the drug, add a second antidepressant, or use pharmacological and non-pharmacological methods of augmenting the effect of pharmacotherapy. New methods that may fall into the scope of multi-module depression treatment as an augmentation of depression treatment are whole body cryotherapy (WBC) and hyperbaric oxygen treatment (HBOT). 545 records were selected and analyzed for these two treatments and finally three clinical trials were selected for analysis. The review also includes data on the possibility of using WBC and HBOT in somatic indications and in organic mental syndromes. Despite the small number of studies on the effectiveness of WBC or HBOT in depression, the current data show that both methods may be effective in the treatment of depression. WBC may be effective in the augmentation of antidepressants, and additionally, it is a method in which a quick antidepressant effect is obtained. HBOT may be effective in endogenous depression, just as it is effective in the treatment of somatic depression symptoms. The results are very preliminary, but if confirmed in subsequent studies, both WBC and HBOT may become new treatment options in treating depression. The authors point to the need and directions for further research into these treatment methods as an augmentation strategy for pharmacological treatment of depression.
Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY).
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.